Corient Capital Partners, LLC Laboratory Corp Of America Holdings Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Corient Capital Partners, LLC holds 1,507 shares of LH stock, worth $354,461. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,507
Previous 1,425
5.75%
Holding current value
$354,461
Previous $334,000
5.69%
% of portfolio
0.03%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding LH
# of Institutions
96Shares Held
1.97MCall Options Held
0Put Options Held
0-
Jana Partners LLC New York, NY402KShares$94.5 Million7.25% of portfolio
-
Cannell & Co. New York, NY341KShares$80.2 Million2.57% of portfolio
-
Bartlett & Co. LLC223KShares$52.4 Million0.82% of portfolio
-
Atlanta Capital Management CO L L C Atlanta, GA198KShares$46.5 Million0.18% of portfolio
-
Credit Suisse Ag Zurich, V8141KShares$33.3 Million0.03% of portfolio
About LABORATORY CORP OF AMERICA HOLDINGS
- Ticker LH
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 89,600,000
- Market Cap $21.1B
- Description
- Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...